TODD A. VALLI - 21 Apr 2025 Form 4 Insider Report for Everi Holdings Inc. (EVRI)

Role
SVP, CAO
Signature
/s/ Todd A. Valli, Attorney-in-Fact
Issuer symbol
EVRI
Transactions as of
21 Apr 2025
Transactions value $
-$412,500
Form type
4
Filing time
22 Apr 2025, 17:31:00 UTC
Previous filing
21 May 2024
Next filing
08 May 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EVRI Common Stock Options Exercise $232K +30K +52.25% $7.74 87.4K 21 Apr 2025 Direct F1
transaction EVRI Common Stock Sale -$413K -30K -34.32% $13.75 57.4K 21 Apr 2025 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EVRI Stock Option Options Exercise -$232K -30K -100% $7.74 0 21 Apr 2025 Common Stock 30K $7.74 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transactions reflected in this Form 4 were effected pursuant to a 10b5-1 plan adopted by the reporting person on December 9, 2024 for options originally granted on April 22, 2015 that would have expired on April 22, 2025.
F2 The price reported in Column 4 of Table I is a weighted average price. The shares were sold in multiple transactions at a price ranging from $13.74 to $13.78. The reporting person undertakes to provide to the Corporation, any security holder of the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 Represents an original option award to purchase 30,000 shares of the Company's common stock, which vested periodically over a period of four years following the date of grant of April 22, 2015.